"Interleukin-1beta" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An interleukin-1 subtype that is synthesized as an inactive membrane-bound pro-protein. Proteolytic processing of the precursor form by CASPASE 1 results in release of the active form of interleukin-1beta from the membrane.
| Descriptor ID |
D053583
|
| MeSH Number(s) |
D12.644.276.374.465.010.600 D12.644.276.374.500.400.600 D12.776.467.374.465.010.600 D12.776.467.374.500.400.600 D23.529.374.465.131.600 D23.529.374.500.400.600
|
| Concept/Terms |
Interleukin-1beta- Interleukin-1beta
- Interleukin 1beta
- IL-1 beta
- Interleukin-1 beta
- Interleukin 1 beta
- Catabolin
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-1beta".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-1beta".
This graph shows the total number of publications written about "Interleukin-1beta" by people in this website by year, and whether "Interleukin-1beta" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 3 | 3 |
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 3 | 3 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 2 | 3 |
| 2019 | 0 | 3 | 3 |
| 2020 | 1 | 3 | 4 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 1 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-1beta" by people in Profiles.
-
Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy. Cell Metab. 2024 Jul 02; 36(7):1521-1533.e5.
-
Response by Nagareddy and Sreejit to Letter Regarding Article, "Retention of the NLRP3 Inflammasome-Primed Neutrophils in the Bone Marrow Is Essential for Myocardial Infarction-Induced Granulopoiesis". Circulation. 2022 05 10; 145(19):e1035-e1036.
-
IL-1ß Impacts Vascular Integrity and Lymphatic Function in the Embryonic Omentum. Circ Res. 2022 02 04; 130(3):366-383.
-
Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1?. Proc Natl Acad Sci U S A. 2021 05 25; 118(21).
-
A Novel Syngeneic Immunocompetent Mouse Model of Head and Neck Cancer Pain Independent of Interleukin-1 Signaling. Anesth Analg. 2021 04 01; 132(4):1156-1163.
-
Selenium-independent antioxidant and anti-inflammatory effects of thioredoxin reductase inhibition in alveolar macrophages. Life Sci. 2020 Oct 15; 259:118285.
-
Attack of the NETs! NETosis primes IL-1?-mediated inflammation in diabetic foot ulcers. Clin Sci (Lond). 2020 06 26; 134(12):1399-1401.
-
Mitochondrial Ceramide Effects on the Retinal Pigment Epithelium in Diabetes. Int J Mol Sci. 2020 May 28; 21(11).
-
Cell-specific and athero-protective roles for RIPK3 in a murine model of atherosclerosis. Dis Model Mech. 2020 01 24; 13(1).
-
Accelerated decline in cognition in a mouse model of increased oxidative stress. Geroscience. 2019 10; 41(5):591-607.